GILEAD SCIENCES, INC. Payments to Acquire Other Productive Assets
GILEAD SCIENCES, INC. (GILD) reported Payments to Acquire Other Productive Assets of $0 for the 9-month period ending 2009-09-30, per its 10-Q filed 2009-11-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherProductiveAssets · last filed 2009-11-05
- GILEAD SCIENCES, INC. payments to acquire other productive assets for the quarter ending 2009-09-30 was $0.00, a 100.00% decline year-over-year.
- GILEAD SCIENCES, INC. payments to acquire other productive assets for the quarter ending 2008-09-30 was $4.08M.
| Period end | Payments to Acquire Other Productive Assets 3 month | Payments to Acquire Other Productive Assets 6 month | Payments to Acquire Other Productive Assets 9 month |
|---|---|---|---|
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $0.00 10-Q · filed 2009-11-05 | |
| 2009-06-30 | $0.00 10-Q · filed 2009-08-05 | ||
| 2008-09-30 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $10.85M 10-Q · filed 2009-11-05 | |
| 2008-06-30 | $6.77M 10-Q · filed 2009-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |